CN103115985A - Hplc-dad法同时测定苦碟子注射液中六种黄酮类成分的方法 - Google Patents
Hplc-dad法同时测定苦碟子注射液中六种黄酮类成分的方法 Download PDFInfo
- Publication number
- CN103115985A CN103115985A CN201310071067XA CN201310071067A CN103115985A CN 103115985 A CN103115985 A CN 103115985A CN 201310071067X A CN201310071067X A CN 201310071067XA CN 201310071067 A CN201310071067 A CN 201310071067A CN 103115985 A CN103115985 A CN 103115985A
- Authority
- CN
- China
- Prior art keywords
- apiolin
- cyanidenon
- phranoglucuronide
- glucopyranoside
- gml
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 55
- 239000007924 injection Substances 0.000 title claims abstract description 45
- 238000002347 injection Methods 0.000 title claims abstract description 45
- 241001412304 Ixeris Species 0.000 title abstract description 9
- 229930003935 flavonoid Natural products 0.000 title abstract description 7
- 150000002215 flavonoids Chemical class 0.000 title abstract description 7
- 235000017173 flavonoids Nutrition 0.000 title abstract description 7
- 239000007788 liquid Substances 0.000 title abstract description 3
- 239000000470 constituent Substances 0.000 title abstract 4
- 238000002156 mixing Methods 0.000 claims abstract description 8
- XBJFCYDKBDVADW-UHFFFAOYSA-N acetonitrile;formic acid Chemical compound CC#N.OC=O XBJFCYDKBDVADW-UHFFFAOYSA-N 0.000 claims abstract description 4
- HQVFCQRVQFYGRJ-UHFFFAOYSA-N formic acid;hydrate Chemical compound O.OC=O HQVFCQRVQFYGRJ-UHFFFAOYSA-N 0.000 claims abstract description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 84
- FBOPMOBFNZUGSZ-UHFFFAOYSA-N 7-O-beta-D-Glucopyranoside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C(OC)=C(OC4C(C(O)C(O)C(CO)O4)O)C=C3O2)O)=C1 FBOPMOBFNZUGSZ-UHFFFAOYSA-N 0.000 claims description 74
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 claims description 74
- 239000000243 solution Substances 0.000 claims description 50
- 241001301715 Crepidiastrum sonchifolium Species 0.000 claims description 37
- 239000011259 mixed solution Substances 0.000 claims description 31
- 239000013558 reference substance Substances 0.000 claims description 31
- 229930003944 flavone Natural products 0.000 claims description 28
- 235000011949 flavones Nutrition 0.000 claims description 28
- 150000002213 flavones Chemical class 0.000 claims description 23
- 239000004615 ingredient Substances 0.000 claims description 23
- 238000012360 testing method Methods 0.000 claims description 12
- 238000002474 experimental method Methods 0.000 claims description 11
- 238000004458 analytical method Methods 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 7
- 238000011084 recovery Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 239000012086 standard solution Substances 0.000 claims description 6
- 238000004090 dissolution Methods 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000012982 microporous membrane Substances 0.000 claims description 3
- 239000012488 sample solution Substances 0.000 abstract 3
- 238000001514 detection method Methods 0.000 abstract 2
- 239000012088 reference solution Substances 0.000 abstract 2
- 239000012528 membrane Substances 0.000 abstract 1
- 238000001471 micro-filtration Methods 0.000 abstract 1
- 239000000523 sample Substances 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000003182 parenteral nutrition solution Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 150000002212 flavone derivatives Chemical class 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 230000002349 favourable effect Effects 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 208000031225 myocardial ischemia Diseases 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 150000007524 organic acids Chemical group 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000002798 spectrophotometry method Methods 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 101000862089 Clarkia lewisii Glucose-6-phosphate isomerase, cytosolic 1A Proteins 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000283073 Equus caballus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000003824 Gypsophila paniculata Species 0.000 description 1
- 240000004460 Tanacetum coccineum Species 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- -1 flavone compounds Chemical class 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000001435 haemodynamic effect Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- KAQKFAOMNZTLHT-OZUDYXHBSA-N prostaglandin I2 Chemical compound O1\C(=C/CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-OZUDYXHBSA-N 0.000 description 1
- 239000010023 qingre quyu Substances 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
- 238000009849 vacuum degassing Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000008215 water for injection Substances 0.000 description 1
Images
Landscapes
- Saccharide Compounds (AREA)
Abstract
Description
成分 | 回归方程 | r | 线性范围(μg·mL-1) |
木犀草素7-O-β-D吡喃葡萄糖苷 | Y= 2.185×104X + 9.962×103 | 0.999 | 2.188~140.0 |
木犀草素7-O-β-D吡喃葡萄糖醛酸苷 | Y = 2.119×104X +5.759×103 | 0.999 | 2.500~160.0 |
芹菜素7-O-β-D吡喃葡萄糖苷 | Y= 2.965×104X -1.176×103 | 0.999 | 0.250~16.00 |
芹菜素7-O-β-D吡喃葡萄糖醛酸苷 | Y = 2.322×104X +4.754×103 | 0.999 | 1.875~120.0 |
木犀草素 | Y = 2.975×104X -2.347×103 | 0.999 | 0.250~16.00 |
芹菜素 | Y= 3.549×104X + 2.449×102 | 0.998 | 0.156~10.00 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310071067.XA CN103115985B (zh) | 2013-03-07 | 2013-03-07 | Hplc-dad法同时测定苦碟子注射液中六种黄酮类成分的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310071067.XA CN103115985B (zh) | 2013-03-07 | 2013-03-07 | Hplc-dad法同时测定苦碟子注射液中六种黄酮类成分的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103115985A true CN103115985A (zh) | 2013-05-22 |
CN103115985B CN103115985B (zh) | 2014-04-02 |
Family
ID=48414412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310071067.XA Active CN103115985B (zh) | 2013-03-07 | 2013-03-07 | Hplc-dad法同时测定苦碟子注射液中六种黄酮类成分的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103115985B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104458995A (zh) * | 2014-12-17 | 2015-03-25 | 通化华夏药业有限责任公司 | 一种采用hplc快速分析苦碟子注射液中黄酮苷及酚酸类有效成分的方法 |
KR20220072490A (ko) * | 2020-11-25 | 2022-06-02 | 청주대학교 산학협력단 | 금전초의 폴리페놀-글루쿠로니드 콘쥬게이트 및 이를 이용한 금전초의 품질평가 방법 |
CN114609298A (zh) * | 2022-03-30 | 2022-06-10 | 湖南中医药大学 | 一种茯苓中三萜酸类化合物含量的测定方法及应用 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050078917A (ko) * | 2004-02-03 | 2005-08-08 | 주식회사 바이오원 | 마과, 씀바귀 및 고들빼기의 추출물을 함유한 복합생약을포함하는 바이러스성 간질환의 예방 및 치료용 조성물 |
CN1762406A (zh) * | 2005-10-11 | 2006-04-26 | 沈阳双鼎制药有限公司 | 苦碟子注射液的质量控制方法 |
CN102283879A (zh) * | 2011-07-19 | 2011-12-21 | 沈阳双鼎科技有限公司 | 一种苦碟子注射液的制备方法和质量控制方法 |
CN102362883A (zh) * | 2011-10-26 | 2012-02-29 | 沈阳双鼎科技有限公司 | 一种苦碟子有效成分组合物的制备、质量控制方法和用途 |
-
2013
- 2013-03-07 CN CN201310071067.XA patent/CN103115985B/zh active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050078917A (ko) * | 2004-02-03 | 2005-08-08 | 주식회사 바이오원 | 마과, 씀바귀 및 고들빼기의 추출물을 함유한 복합생약을포함하는 바이러스성 간질환의 예방 및 치료용 조성물 |
CN1762406A (zh) * | 2005-10-11 | 2006-04-26 | 沈阳双鼎制药有限公司 | 苦碟子注射液的质量控制方法 |
CN102283879A (zh) * | 2011-07-19 | 2011-12-21 | 沈阳双鼎科技有限公司 | 一种苦碟子注射液的制备方法和质量控制方法 |
CN102362883A (zh) * | 2011-10-26 | 2012-02-29 | 沈阳双鼎科技有限公司 | 一种苦碟子有效成分组合物的制备、质量控制方法和用途 |
Non-Patent Citations (4)
Title |
---|
RAN YIN等: "Determination of five components in Ixeris sonchifolia by high performance liquid chromatography", 《JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS》 * |
张晶等: "高效液相色谱法测定抱茎苦荬菜中木樨草素及芹菜素的含量", 《时珍国医国药》 * |
萨仁格日乐等: "HPLC同时测定蒙药光叶苦荬菜中5种有效成分的含量", 《中国实验方剂学杂志》 * |
陈英红等: "高效液相色谱法同时测定苦碟子中四种黄酮的含量", 《中国药师》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104458995A (zh) * | 2014-12-17 | 2015-03-25 | 通化华夏药业有限责任公司 | 一种采用hplc快速分析苦碟子注射液中黄酮苷及酚酸类有效成分的方法 |
KR20220072490A (ko) * | 2020-11-25 | 2022-06-02 | 청주대학교 산학협력단 | 금전초의 폴리페놀-글루쿠로니드 콘쥬게이트 및 이를 이용한 금전초의 품질평가 방법 |
KR102571145B1 (ko) | 2020-11-25 | 2023-08-25 | 청주대학교 산학협력단 | 금전초의 폴리페놀-글루쿠로니드 콘쥬게이트 및 이를 이용한 금전초의 품질평가 방법 |
CN114609298A (zh) * | 2022-03-30 | 2022-06-10 | 湖南中医药大学 | 一种茯苓中三萜酸类化合物含量的测定方法及应用 |
CN114609298B (zh) * | 2022-03-30 | 2024-05-10 | 湖南中医药大学 | 一种茯苓中三萜酸类化合物含量的测定方法及应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103115985B (zh) | 2014-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107727753B (zh) | 百乐眠胶囊指纹图谱的建立方法 | |
CN103149301B (zh) | Hplc-dad法同时测定苦碟子注射液中10种核苷类成分含量的方法 | |
CN108279278B (zh) | 一种分离黄酮类成分的方法及其应用 | |
CN110736799B (zh) | 一种中药小儿解感颗粒的质量检测方法 | |
CN103115985B (zh) | Hplc-dad法同时测定苦碟子注射液中六种黄酮类成分的方法 | |
CN103163243B (zh) | Hplc-dad法同时测定苦碟子注射液中五种有机酸类成分含量的方法 | |
CN114252532B (zh) | 一种防风通圣颗粒指纹图谱的建立方法及其指纹图谱 | |
CN104007198B (zh) | 一种灵芝皇制剂hplc标准指纹图谱及其构建方法和应用 | |
CN105911192A (zh) | 一种半枫荷活血化瘀活性部位的提取方法及指纹图谱检测方法 | |
CN103630633A (zh) | 一种柱前衍生化法测定苦碟子注射液中6种氨基酸含量的方法 | |
CN102707006B (zh) | 穿破石配方颗粒的质量检测方法 | |
CN102846704B (zh) | 一种益母草注射液、其制备方法和总生物碱的检测方法 | |
CN105158352B (zh) | 一种冠心宁片的指纹图谱的建立方法及其应用 | |
CN103675135B (zh) | 一种中药组合物的含量测定方法 | |
CN102078503A (zh) | 生脉饮中药制剂的检测方法 | |
CN101380362B (zh) | 伤科接骨药物制剂中挥发性成分气相色谱指纹图谱检测方法 | |
CN103091408B (zh) | 柑橘生物类黄酮中橙皮甙含量的测定方法 | |
CN107064325A (zh) | 一种芪葛颗粒的质量控制方法 | |
CN112946118A (zh) | 一种药物指纹图谱的测定方法及其指纹图谱 | |
CN103454373B (zh) | 一种治疗痛经的药物的检测方法 | |
CN112618630A (zh) | 复方血栓通软胶囊及复方血栓通软胶囊的质量检测方法 | |
CN101493445A (zh) | 蜂胶中阿魏酸含量的测定方法 | |
CN105285623B (zh) | 一种具有提高免疫功能的保健饮料及其制法 | |
CN104950063B (zh) | 银黄颗粒中绿原酸含量测定方法 | |
CN103105450A (zh) | 一种透骨草配方颗粒的质量检测方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Simultaneous determination of six flavonoids in Kudiezi Injection by HPLC-DAD Effective date of registration: 20210610 Granted publication date: 20140402 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: TONGHUA HUAXIA PHARMACEUTICAL Co.,Ltd. Registration number: Y2021220000060 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220823 Granted publication date: 20140402 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: TONGHUA HUAXIA PHARMACEUTICAL Co.,Ltd. Registration number: Y2021220000060 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Simultaneous determination of six flavonoids in Kudiezi injection by HPLC-DAD Effective date of registration: 20220826 Granted publication date: 20140402 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: TONGHUA HUAXIA PHARMACEUTICAL Co.,Ltd. Registration number: Y2022220000059 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230905 Granted publication date: 20140402 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: TONGHUA HUAXIA PHARMACEUTICAL Co.,Ltd. Registration number: Y2022220000059 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Simultaneous Determination of Six Flavonoids in Kudiezi Injection by HPLC-DAD Method Effective date of registration: 20230926 Granted publication date: 20140402 Pledgee: Tonghua Branch of China Everbright Bank Co.,Ltd. Pledgor: TONGHUA HUAXIA PHARMACEUTICAL Co.,Ltd. Registration number: Y2023220000098 |